The stimulation of the renin–angiotensin–aldosterone system (RAAS) enhances the activation of angiotensin II (Ang II), a peptide linked to cardiovascular diseases (CVDs) [1,2,3,4,5,6]. Here, AGT is linked to cardiovascular disorder.